Remove 2019 Remove Commission Remove Numbers Remove Portfolio
article thumbnail

Coromandel International Vs FACT – Financials, Future Plans & More

Trade Brains

Its product portfolio comprises various types of fertilizers, crop protection chemicals, speciality nutrients, and biopesticides. Fiscal Year Coromandel International FACT 2019 13,204 1954.59 While Coromandel Internationals has reported net profits in greater numbers, the 4-year profit CAGR of Fact Ltd is better. Crores in FY23.

article thumbnail

Fundamental Analysis Of CE Info Systems (Map My India) – Future Plans & More

Trade Brains

The SaaS companies in India saw growth of 2x in global market share as well as in the number of internet users. Revenue grew from FY 2019 to FY 2023 at a CAGR of 20.11%. Net profits increased at a CAGR of 33.19% from FY 2019 to FY 2023. 2019-20 148.63 2019-20 0 12.14 crore in FY23 as compared to Rs. 2021-22 200.44

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Alkyl Amines Vs Balaji Amines – Financials, Future Plans & More

Trade Brains

The characteristics & applications of amines allow for a number of industrial uses and new product development. They have a product portfolio of 100+ products which they cater to 20+ countries across the globe through their 20 individual production plants over three manufacturing sites covering over 110 acres of land.

article thumbnail

Navigating Geopolitical Events

ClearMoney

If markets stay open and continue to function normally, we generally continue investing our portfolios according to our usual process. If imposed, they would add to sanctions on Russia that have been in place for a number of years. Flexibility is valuable in managing portfolios through these events. The Value of Flexibility.

article thumbnail

Fundamental Analysis of Glenmark Life Sciences – Future Plans & More

Trade Brains

Since then the segment grew exponentially until it was hived off in 2019 and listed separately as Glenmark Life Sciences in 2021. It has a portfolio of 137 API products with 26 more products in the pipeline. This can be gauged from the fact that the nation accounts for the most number of DMFs applied in the United States at 15%.

article thumbnail

BLS E-Services IPO Review – GMP, Financials and More

Trade Brains

The Company generates revenue from monthly commissions, transaction-based commissions, and Registration Fees. To address this issue the Department of Administrative Reforms & Public Grievances (DARPG) formulated the National e-Governance Service Delivery Assessment (NeSDA) in 2019. So would you be applying for this IPO?

article thumbnail

Fundamental Analysis of Hindustan Zinc – Financials, Future Plans & More

Trade Brains

Financial Year Operating Revenue Net Profit 2023 34,098 10,511 2022 29,440 9,629 2021 22,629 7,980 2020 18,561 6,805 2019 21,118 7,956 5-Yr CAGR 10.06% 5.73% (figures in Rs Cr except for CAGR) To suit investors’ interests, profit should grow at a faster or the same pace as revenues. 76 2019 0.08 Did it earn stellar profits?